My path to molecular biology started from a general interest in science and slowly developed into my passion and a career here at Ingenza that I enjoy very much. I did my undergraduate degree in biomedical sciences at the University…
Ingenza is thrilled to have received support for its Unleashing Putida: Biobased Methacrylates for a Sustainable Future project with the award of a grant from Innovate UK and Eureka. This ground-breaking research is being undertaken in collaboration with Mitsubishi Chemical…
Ingenza is pleased to announce the award of two Innovate UK Sustainable Innovation Fund grants amounting to £232K. These grants will support two cutting edge projects in carbon use efficiency, which will reap major benefits for Ingenza while supporting the…
One of the biggest challenges of our generation will be to reverse the effects of climate change caused by the long-term increase in CO2 emissions. In theory, there are two ways to approach this problem, either by dealing with the…
If you’ve read my last blog, you’ll already know that I’m Team Leader of Operations and Marketing at Ingenza, a role that is incredibly busy and varied, and that I absolutely love. So it might not be surprising to hear…
Biotechnology company Ingenza is proud to be celebrating its 10th year of collaboration with Teesside-based Lucite International (LI). LI is the world’s largest producer of methyl-methacrylate (MMA) – the building block of acrylic – and has partnered with Ingenza to…
I first came across Ingenza during my PhD at the University of Strathclyde, where I was fortunate enough to work in the same research group as Ali Arnold – Head of Fermentation at Ingenza – and the company stayed on…
Dr Ian Fotheringham, Managing Director and founder of Ingenza, has been awarded an MBE for services to Industrial Biotechnology in the Queen’s Birthday Honours List. This accolade recognises Ian’s position as a well-known industrial biotechnology expert. He originally gained extensive…
Ingenza’s ambitious SYNBIOPRO project for the development of biopharmaceuticals continues to make significant progress, despite the global disruption caused by the COVID-19 pandemic. Supported by a Scottish Enterprise research and development (R&D) grant since 2018, this project has hit a…